ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $206,000 | -88.1% | 1,195 | -91.3% | 0.00% | -84.2% |
| Q2 2021 | $1,728,000 | +284.0% | 13,767 | +244.2% | 0.02% | +171.4% |
| Q3 2020 | $450,000 | -92.7% | 4,000 | -93.8% | 0.01% | -93.4% |
| Q2 2020 | $6,141,000 | +537.7% | 64,457 | +501.6% | 0.11% | +307.7% |
| Q1 2020 | $963,000 | -52.9% | 10,715 | -72.2% | 0.03% | -29.7% |
| Q4 2019 | $2,044,000 | +1810.3% | 38,543 | +1325.4% | 0.04% | +1750.0% |
| Q3 2019 | $107,000 | -84.3% | 2,704 | -83.7% | 0.00% | -83.3% |
| Q2 2019 | $680,000 | +210.5% | 16,557 | +252.3% | 0.01% | +71.4% |
| Q1 2019 | $219,000 | +376.1% | 4,700 | +483.1% | 0.01% | +133.3% |
| Q3 2018 | $46,000 | -82.2% | 806 | -84.9% | 0.00% | -76.9% |
| Q2 2018 | $259,000 | +362.5% | 5,339 | +254.5% | 0.01% | +333.3% |
| Q3 2017 | $56,000 | +1020.0% | 1,506 | +653.0% | 0.00% | – |
| Q1 2017 | $5,000 | -99.0% | 200 | -99.0% | 0.00% | -100.0% |
| Q1 2016 | $520,000 | – | 19,691 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |